Welcome to the Gevo, Inc. Fourth Quarter 2017 Earnings Conference Call. My name is Brandon and I'll be your operator for today. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] Please note this conference is being recorded and I will now turn it over to Geoffrey T. Williams, Jr. Sir, you may begin.

Good afternoon, everyone, and thank you for joining Gevo's fourth quarter 2017 earnings conference call. I would like to start by introducing today's participants from the Company. With us today is Pat Gruber, Gevo's Chief Executive Officer, and Bradford Towne, Gevo's Chief Accounting Officer. Earlier today, we issued a press release that outlines the topics we plan to discuss today. A copy of this press release is available on our Web-site at www.gevo.com. I would like to remind our listeners that this conference call is open to the media and we are providing a simultaneous Webcast of this call to the public. A replay of today's call will be available on Gevo's Web-site. On the call today and in this Webcast, you will hear discussions of certain non-GAAP financial measures. Non-GAAP financial measures should not be considered in isolation from or as a substitute for financial information presented in accordance with GAAP. Reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the press release distributed today and which is posted on our Web-site. We will also make certain forward-looking statements about events and circumstances that have not yet occurred, including, but not limited to, projections about Gevo's operating activities for the remainder of 2018 and beyond. These forward-looking statements are based on management's current beliefs, expectations and assumptions, and are subject to significant risks and uncertainties, including those disclosed in Gevo's Form 10-K for the year ended December 31, 2017, which will be filed with the U.S. Securities and Exchange Commission on or about March 28, 2018, and in subsequent reports and other filings made with the SEC by Gevo, including our quarterly reports on Form 10-Q. Investors are cautioned not to place undue reliance on any such forward-looking statements. Such forward-looking statements speak only as of today's date and Gevo disclaims any obligations to update information contained in these forward-looking statements, whether as a result of new information, future events or otherwise. On today's call, Pat will begin with a discussion of Gevo's business developments. Bradford will then review Gevo's financial results for the fourth quarter of 2017. Following the presentation, we will open up the call for questions. I'll now turn the call over to Pat.

Thank you, Geoff. I'll now talk about some of the highlights of the quarter and the year. I'll start by mentioning that at the beginning of the year of 2017 we saw just a few ethanol-free gasoline pumps at retail locations, but by the end of the year this number had grown to almost 200 different pumps. This gave us all confidence to expand our relationship with Musket. Now along the way we did a market study for the niche market where our product might be particularly valued. A company called Stillwater Associates, they are pretty well known in this space, did the work. They found that the total ethanol-free market is estimated about 7 billion gallons in the U.S. alone. That's not a bad sized niche. About 2 billion gallons of that estimated market is in RFG areas. Those are the areas that require oxygen in gasoline. As you all know, those RFG areas, they are our current focus. This specialty, this large niche market does have the hassles of a specialty market in setting up distribution, but we think the payoff will be worth it in the end. Second, we have been developing the EU market for isooctane. Isooctane is used for renewable gasoline among other things. Isooctane really is the octane of gasoline, the major component in gasoline. We've been able to sell the entire volume produced at our demo plant. Of course you know that we have Haltermann Carless as a customer, both from the demo plant and they also made a commitment to purchase from our expanded plant once we build out Luverne. We also have BP, Total, BCD Chemie as customers. Based on the interest and the prices customers are willing to pay for isooctane, we believe that there is a strong market for…

Thank you, Pat. Gevo reported revenue in the fourth quarter of 2017 of $6.7 million as compared to $5.8 million in the same period in 2016. The increase in revenue during 2017 is primarily a result of the production and sale of approximately $6.6 million of ethanol, isobutanol and distiller grains at the Luverne plant, as compared to $5.3 million in the fourth quarter of 2016. This increase in revenue was mainly due to higher ethanol production and distiller grain prices in the fourth quarter of 2017 versus the same period in 2016. During the fourth quarter of 2017, hydrocarbon revenues were approximately $50,000, which is $0.4 million lower than in the same period in 2016, principally as a result of the shipment of less isooctane this quarter. Cost of goods sold was $9.3 million in the fourth quarter of 2017 versus $8.2 million in the same period in 2016. Cost of goods sold included approximately $7.8 million associated with the production of ethanol, isobutanol, and related products, and approximately $1.5 million in depreciation expense. Gross loss was $2.3 million for the fourth quarter of 2017 versus $2.3 million for the fourth quarter of 2016. R&D expense for the fourth quarter of 2017 decreased to $0.9 million compared $1.5 million reported for the comparable quarter in 2016. This was due primarily to a $0.4 million decrease in salary and related expenses. SG&A expenses for the fourth quarter of 2017 decreased to $1.3 million compared to $2.6 million for the comparable quarter in 2016. This was due primarily to a $1.1 million decrease in salary and related expenses. Within total operating expenses for the fourth quarter of 2017, we reported approximately $0.1 million for non-cash stock-based compensation. For the fourth quarter of 2017, we reported a loss from operations of $4.8…

[Operator Instructions] From H.C. Wainwright, we have Amit on line. Amit Dayal, please go ahead.

So, in terms of the burn and lowering cost, et cetera, like how should we look at what you guys are doing to continue extending the runway on some of these options materializing?

I think what we put out there was 30% less at least when compared to 2017, and as we make improvements or adjust from there, we'll update in the future. There are things we are doing both in terms of, I mentioned on the call, in my remarks that we have opportunity to sell more isooctane out of Silsbee. We got to go make that happen. That will help add cash. We have opportunities to sell more isobutanol as we expand regions. That will add value because that's just taken out of inventory. In the meantime – and there are some improvements that we plan on making, that we desire to make, and we are working to make happen up at Luverne just to improve the profitability of the plant potentially quite dramatically, but it's just not baked in stone yet, so I'm not commenting on it publicly.

And on the licensing front with partners like Praj, et cetera, is there any sort of realistic progress towards something materializing in 2018 with these guys?

From the standpoint of, we made progress all the way along. It takes – these agreements are kind of complicated to negotiate because we have to do a license deal with Praj, we have one with Praj to help develop technology to adapt this to the molasses. We have done that successfully. The stuff works for molasses. Then we have been recruiting partners to figure out how to do those details specifically and who is paying for what exactly. I mean, obviously I'm not putting up capital or help anything like that. I just want to be paid a license fee. So, how much license fee, what are the details exactly, where is the stuff going to be sold exactly, all of that stuff matters to us and has to be pinned down. And so, it's in India, the target companies are in India. They are relatively small plants because Praj wants to prove a point about how this works plus molasses plants are generally small inside of India anyway. So, it's making progress. There are other opportunities that have popped up in other places in the world that are just premature to talk about. We'll have to see what happens. But it's the first time we are doing these license agreements and between – we're just doing it very deliberately, very carefully. Recall that we had a Butamax settlement. And so, the two of us, Butamax and we own the technology for [around $1] [ph] and we have cross-licensed to each other. So we have to take that into consideration too as to how to handle it. So, it's just time consuming, that's all.

Great. One question on maybe catalysts around the ATJ side, what should we expect over the next few quarters, like what needs to materialize for some of these things to continue progressing, if you could outline some of these things for us?

What I think it would be is customer contracts. There are a couple that we are still negotiating. The ones you should know about are already out there being discussed. It's a question of – it's their timelines, it's not mine. But we continue to make progress on them to the point of I know we are creating contracts in some cases. So I know that that's progress. People don't spend money on lawyers otherwise. I just don't know when this stuff will finally get done. And then I think this isooctane thing that I talked about, we have never really talked about that in detail on one of these calls, but it's worth noting just we're the only ones in the world who can make fully renewable isooctane. That turns out that it matters. People are paying pretty big bucks for it per gallon out of the plant in Silsbee, it's all going to Europe, no RINS involved, nothing like that at all. People forget that. That's important. And I think that's going to be a long-term market for us too. There is a question of how many millions of gallons [indiscernible] and at what price, but from what we can tell, it's definitely an attractive niche that I think we are the only ones in the world in a position to deal with who can serve that market. So, that's the one that Haltermann is focused on. Some of the other companies have played in that space too. So that's pretty darn interesting.

So how can that potentially be sort of scaled up? If you are getting a lot of traction it looks like on that front, are you adding any resources to build that out further or is that a little bit more [indiscernible]?

What I would hope to do is there are some process changes that we can make down at the plant at Silsbee that gets us more immediate capacity, so we can start selling more of this stuff. Then it's a question of what are the next steps. Is the demand big enough and firm enough where we can support the buildout of Luverne? Maybe. We are going to try and see if that's the case. How long will it take? Don't know. We've had pretty big requests in the next couple of years for isooctane, but that intermediate size, we'd have to decide how to serve it because obviously I'm not keen – sure, they want to put up the money, I'm all for it, but I'm not real keen at just raising money and taking the risk ourselves. We're going to have to have it pretty firm. So, those are the kind of discussions that we think about as we are doing this. And I would add to this that remember what we do, is we start with isobutanol and make butylene. Butylene is the building block. We get several requests for butylene. We just haven't put – we got to pin down more of what those economics are. In the long run it makes perfect sense, but I'll tell you, we get paid so much more for making isooctane that it's hard to justify butylene at this point.

Perfect. And just one maybe final one for me, in terms of the overhead reduction and the cost cutting, et cetera, is that all done now and should we start seeing some of those benefits?

We have seen benefits already. You have already seen some of them in the fourth quarter, and so you have seen – yes, we will continue to realize some of those benefits. I can say that I'll be adding back certain resources too that help us as a company, when I'll be announcing those at the right time.

Great. Thank you, Pat. That's all I have. Thank you.

All right then, appreciate all you guys' support. Thank you for joining us on the call today. Bye-bye.

Thank you. Ladies and gentlemen, this concludes today's conference. Thank you for joining. You may now disconnect.